A new treatment for perioperative pain management.
Combogesic® IV’s patented 3.3 to 1 paracetamol to ibuprofen ratio has been proven to provide significantly better pain relief than the same dose of either paracetamol IV or ibuprofen IV alone.
Combogesic® IV was developed to provide a combination analgesic therapy with the administration of a single formulation in perioperative patients unable to receive oral analgesics.
Paracetamol 1000 mg and ibuprofen 300 mg in 100 mL solution for infusion.
Combogesic IV will be given to you by a healthcare professional by infusion into one of your veins.
The infusion should be administered over 15 minutes.
This medicine is for short term use only, maximum 2 days.
The recommended dose is:
For adults who weigh more than 50 kg: 1 vial every 6 hours, as required.
The maximum daily dose is four vials which equals 4000 mg (4 g) paracetamol and 1200 mg (1.2 g) ibuprofen.
If you weigh 50 kg or less, are elderly or if you have liver or kidney problems:
Your doctor may decide to reduce your dose or increase the time between doses because of the increased risk of side effects.
No warnings available
10s
Vial
May 1, 2024
We are delighted to announce our partnership with Brazil’s Halex Istar, and to be exclusively responsible for distributing its Maxigesic IV in Brazi…
April 24, 2024
AFT collaborate with Massey Ventures and Gilles McIndoe to begin the development of a topical treatment for keloid and hypertrophic scarring….
March 5, 2024
AFT Pharmaceuticals provides an update on recent progress it has made in international markets….